減価償却累計額、関係会社株式評価損、資本金他1件
- 【期間】
| 年度 | 減価償却累計額 | 関係会社株式評価損 | 資本金 | 減価償却費 - 薬品事業 |
|---|
| 2007/03 | - | | - | | 45.6億 | | - | |
| 2008/03 | -24億 | | - | | 45.6億 | ±0% | - | |
| 2009/03 | -24.9億 | 赤拡 | - | | 45.6億 | ±0% | - | |
| 2010/03 | -26.5億 | 赤拡 | - | | 45.6億 | ±0% | - | |
| 2011/03 | -27.9億 | 赤拡 | 103百万 | | 45.6億 | ±0% | - | |
| 2012/03 | -29.9億 | 赤拡 | - | | 45.6億 | ±0% | - | |
| 2013/03 | -31.1億 | 赤拡 | - | | 45.6億 | ±0% | 7.83億 | |
| 2014/03 | - | | - | | 45.6億 | ±0% | 8.56億 | +9.3% |
| 2015/03 | - | | - | | 45.6億 | ±0% | 10.5億 | +22.7% |
| 2016/03 | - | | - | | 45.6億 | ±0% | 11.7億 | +11.5% |
| 2017/03 | - | | - | | 45.6億 | ±0% | 11.5億 | -1.5% |
| 2018/03 | - | | - | | 45.6億 | ±0% | 12.6億 | +9.4% |
| 2019/03 | - | | 117百万 | +13.6% | 45.6億 | ±0% | 14.6億 | +15.6% |
| 2020/03 | - | | - | | 45.6億 | ±0% | 17.4億 | +19.3% |
| 2021/03 | - | | - | | 45.6億 | ±0% | 14.5億 | -16.6% |
| 2022/03 | - | | 255百万 | +117.9% | 45.6億 | ±0% | 15.6億 | +7.7% |
| 2023/03 | - | | - | | 45.6億 | ±0% | 15.7億 | +0.1% |
| 2024/03 | - | | - | | 45.6億 | ±0% | - | |
